Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1154-1161

  Pollock, Pamela M ^a   Welch, John ^b   Hayward, Nicholas K ^b  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

ALLELE; ARTICLE; CANCER GROWTH; CHROMOSOME 9P; CHROMOSOME MAP; DNA FLANKING REGION; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MARKER GENE; MELANOMA; POINT MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 9; GENES, P16; GENES, TUMOR SUPPRESSOR; HOMOZYGOTE; HUMANS; LOSS OF HETEROZYGOSITY; MELANOMA; MICROSATELLITE REPEATS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SKIN NEOPLASMS;

EID: 0035119327     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Increasing incidence of cutaneous melanoma in Queensland, Australia
2. INK4A) somatic and germline mutations
3. Compilation of somatic mutations of the CDKN2 gene in human cancers: Non-random distribution of base substitutions
4. The CDKN2A (p16) gene and human cancer
5. The p16INK4a/CDKN2A tumor suppressor and its relatives
6. Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma
7. p16 gene in uncultured tumours
8. Rates of pl6 (MTS1) mutations in primary tumors with 9p loss
9. p16(INK4a) and the control of cellular proliferative life span
10. Homozygous deletions of 9p21 in primary human bladder tumors detected by comparative multiplex polymerase chain reaction
11. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours
12. Loss of heterozygosity and homozygous deletions on 9p21-22 in melanoma
13. Chromosome 9p deletions in cutaneous malignant melanoma tumors: The minimal deleted region involves markers outside the p16 (CDKN2) gene
14. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma
15. Retention of the CDKN2A locus and low frequency of point mutations in primary and metastatic cutaneous malignant melanoma
16. Identification of a novel region of homozygous deletion on chromosome 9p in squamous cell carcinoma of the lung: The location of a putative tumor suppressor gene
17. Frequent loss of heterozygosity in early non-small cell lung cancers at chromosome 9p21 proximal to the CDKN2a gene
18. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: The deleted region involves markers outside of the MTS1 and MTS2 genes
19. Genetic alterations of chromosome band 9p21-22 in head and neck cancer are not restricted to p16INK4a
20. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer
21. Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome-9 deletion
22. Two regions of deletion in 9p23-24 in sporadic breast cancer
23. Localization of a novel tumor suppressor gene loci on chromosome 9p21- 22 in oral cancer
24. Refined localization of the melanoma (MLM) gene on chromosome 9p by analysis of allelic deletions
25. Germline p16 mutations in familial melanoma
26. CDKN2A/p16 is inactivated in most melanoma cell lines
27. p16/CDKN2, and CDK4 gene mutations in sporadic melanoma development and progression
28. Homozygous deletions within human chromosome band 9p21 in melanoma
29. Genomic organization and mutation analysis of Hel-N1 in lung cancers with chromosome 9p21 deletions
30. Mutational analysis of the Hel-N1 gene in childhood acute lymphoblastic leukemia with LOH at 9p21
31. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma
32. Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumor suppression
33. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas
34. INK4bgenes, as well as neighboring 9p21 markers, in sporadic melanoma
35. Infrequent mutation of p16INK4 in sporadic melanoma
36. Mutational analysis of the CDKN2 gene in metastases from patients with cutaneous malignant melanoma
37. Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo
38. Low frequency of p16/CDKN2A methylation in sporadic melanoma: Comparative approaches for methylation analysis of primary tumors
39. Mutations in the CDKN2A (p16INK4a) gene in microdissected sporadic primary melanomas
40. UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas
41. p16INK4a inactivation is not frequent in uncultured sporadic primary cutaneous melanoma
42. Loss of heterozygosity at chromosome 9p21 (INK4-p14ARF locus): Homozygous deletions and mutations in the p16 and p14ARF genes in sporadic primary melanomas